Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
254,692
-
Share change
-
-56,606
-
Total reported value
-
$560,000
-
Price per share
-
$2.20
-
Number of holders
-
15
-
Value change
-
-$195,359
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q3 2021
As of 30 Sep 2021,
Scinai Immunotherapeutics Ltd. - ADSs (BVXV) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
254,692 shares.
The largest 10 holders included
STATE STREET CORP, MORGAN STANLEY, HRT FINANCIAL LP, TRUE Private Wealth Advisors, Virtu Financial LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, CREDIT AGRICOLE S A, UBS Group AG, and ROYAL BANK OF CANADA.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.